UIG News
About UIG
References
UIG Services
Contact Us
South Korea’s Samsung Bioepis wins U.S. FDA nod for biosimilar of J&J’s Remicade
South Korea's Samsung Bioepis wins U.S. FDA nod for biosimilar of J&J's Remicade.
«
It’s a monster week for ...
First coal-free day in Britain...
»